Associated Papers
Comprehensive biomarker analyses identifies HER2, EGFR, MET RNA expression and thymidylate synthase 5'UTR SNP as predictors of benefit from S-1 adjuvant chemotherapy in Japanese patients with stage II/III gastric cancer.
Yoshikawa T et al.
Journal of Cancer, 2019
SNPs in predicting clinical efficacy and toxicity of chemotherapy: walking through the quicksand.
Palmirotta R et al.
Oncotarget, 2018
Colorectal cancer in Chinese patients: current and emerging treatment options.
Li L et al.
Oncotargets and Therapy, 2014
Pharmacogenetics for individualized cancer chemotherapy.
Efferth T et al.
Pharmacology & Therapeutics, 2005
Select a paper to view details